CID 16197373

Succinyl-qelleldkwaslwnwf-nh2

Structural Information

Molecular Formula
C111H153N25O29
SMILES
C[C@H]1C(=O)N[C@@H](CCC(=O)NCCCCCNC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CNC3=CC=CC=C32)CCCCN)CC(=O)O)CC(C)C)CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC4=CNC5=CC=CC=C54)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)N[C@@H](CC8=CC=CC=C8)C(=O)N
InChI
InChI=1S/C111H153N25O29/c1-58(2)46-79(129-102(156)76(34-40-92(142)143)125-99(153)73(31-36-87(113)137)122-91(141)39-42-94(146)147)105(159)127-75-33-38-90(140)117-45-21-9-20-44-116-89(139)37-32-74(123-97(151)61(7)121-104(158)82(50-63-55-118-69-27-15-12-24-66(63)69)132-98(152)72(30-18-19-43-112)124-111(165)86(54-95(148)149)136-107(161)81(48-60(5)6)131-103(157)77(126-100(75)154)35-41-93(144)145)101(155)130-80(47-59(3)4)106(160)133-84(52-65-57-120-71-29-17-14-26-68(65)71)109(163)135-85(53-88(114)138)110(164)134-83(51-64-56-119-70-28-16-13-25-67(64)70)108(162)128-78(96(115)150)49-62-22-10-8-11-23-62/h8,10-17,22-29,55-61,72-86,118-120H,9,18-21,30-54,112H2,1-7H3,(H2,113,137)(H2,114,138)(H2,115,150)(H,116,139)(H,117,140)(H,121,158)(H,122,141)(H,123,151)(H,124,165)(H,125,153)(H,126,154)(H,127,159)(H,128,162)(H,129,156)(H,130,155)(H,131,157)(H,132,152)(H,133,160)(H,134,164)(H,135,163)(H,136,161)(H,142,143)(H,144,145)(H,146,147)(H,148,149)/t61-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-/m0/s1
InChIKey
DRUVYBWWJREOBF-ODIIFNLDSA-N
Compound name
(4S)-5-[[(2S)-1-[[(2S,5S,8S,11S,14S,17S,20S,34S)-20-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]-11-(4-aminobutyl)-2-(2-carboxyethyl)-8-(carboxymethyl)-14-(1H-indol-3-ylmethyl)-17-methyl-5-(2-methylpropyl)-3,6,9,12,15,18,23,31,35-nonaoxo-1,4,7,10,13,16,19,24,30-nonazacyclopentatriacont-34-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-5-amino-2-(3-carboxypropanoylamino)-5-oxopentanoyl]amino]-5-oxopentanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2300.1267 Da
Monoisotopic Mass

-2.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2301.1340 310.9
[M+Na]+ 2323.1159 301.1
[M-H]- 2299.1194 312.7
[M+NH4]+ 2318.1605 304.5
[M+K]+ 2339.0899 296.4
[M+H-H2O]+ 2283.1240 275.9
[M+HCOO]- 2345.1249 302.5
[M+CH3COO]- 2359.1406 302.4
[M+Na-2H]- 2321.1014 336.9
[M]+ 2300.1262 286.2
[M]- 2300.1272 286.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.